How does JPMorgan U.S. Value Fund Class A (NASDAQ: VGRIX) compare with companies in other sectors?

VGRIX on the NASDAQ trades at a P/E of N/A with a net margin of 0.00% and ROE of 0.00%, which positions it against peers in the Financial Services sector and beyond.

What are VGRIX's (NASDAQ) net and operating margins?

On the NASDAQ, VGRIX reports a net profit margin of 0.00% and an operating margin of 0.00%.

In what way does VGRIX's (NASDAQ) EPS trend reflect its financial momentum?

VGRIX's EPS growth on the NASDAQ is 0.00% and its 5-year EPS CAGR is 0.00%, indicating its earnings momentum.

What does VGRIX's (NASDAQ) ROE tell investors?

VGRIX on the NASDAQ posts an ROE of 0.00%, showing how much profit JPMorgan U.S. Value Fund Class A generates for every $100 of shareholder equity.

How do I know if VGRIX (NASDAQ) is overvalued or undervalued?

VGRIX on the NASDAQ trades at a P/E of N/A and a PEG of N/A; compared with the P/E benchmark of 21.06, this suggests valuation should be reviewed against sector peers.

JPMorgan U.S. Value Fund Class A Fundamental Analysis (NASDAQ: VGRIX)

VGRIX●NASDAQ

Financial ServicesAsset Management

$95.57

$0.12(0.13%)

U.S. Market opens in 36h 41m

JPMorgan U.S. Value Fund Class A Fundamental Analysis (NASDAQ: VGRIX)

JPMorgan U.S. Value Fund Class A (NASDAQ: VGRIX) shows weak financial fundamentals with a PE ratio of N/A, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze VGRIX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze VGRIX's fundamental strength across five key dimensions:

Efficiency Score

Weak

VGRIX struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Weak

VGRIX trades at a premium to fair value.

PE < 25

N/A

PEG Ratio < 2

N/A

Growth Score

Weak

VGRIX faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

VGRIX carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

VGRIX struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is VGRIX Expensive or Cheap?

No data available.

How Well Does VGRIX Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How VGRIX Stacks Against Its Sector Peers

Metric	VGRIX Value	Sector Average	Performance
P/E Ratio	N/A	21.06	N/A
ROE	N/A	651.00%	N/A
Net Margin	N/A	-599.00% (disorted)	N/A
Debt/Equity	N/A	0.88	N/A
Current Ratio	N/A	887.27	N/A
ROA	N/A	6570.00%	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews JPMorgan U.S. Value Fund Class A's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Value, Dividend, Cyclical

EPS CAGR

N/A

Industry Style: Value, Dividend, Cyclical

FCF CAGR

N/A

Industry Style: Value, Dividend, Cyclical

JPMorgan U.S. Value Fund Class A Fundamental Analysis (NASDAQ: VGRIX)

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is VGRIX Expensive or Cheap?

How Well Does VGRIX Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How VGRIX Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

How does JPMorgan U.S. Value Fund Class A (NASDAQ: VGRIX) compare with companies in other sectors?

What are VGRIX's (NASDAQ) net and operating margins?

In what way does VGRIX's (NASDAQ) EPS trend reflect its financial momentum?

What does VGRIX's (NASDAQ) ROE tell investors?

How do I know if VGRIX (NASDAQ) is overvalued or undervalued?